Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats

Biological Trace Element Research

Volumn 104, Issue 3, 2005, Pages 233-247

  Koyuturk, Meral ^a   Tunali, Sevim ^b   Bolkent, Sehnaz ^b   Yanardag, Refiye ^b  

^a KADIR HAS UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Biochemistry; Electron microscopy; Light microscopy; Liver tissue; Streptozotocin; Vanadyl sulfate

Indexed keywords

ALKALINE PHOSPHATASE; GLUCOSE; VANADYL SULFATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; LIPID PEROXIDATION; LIVER; MALE; MICROSCOPY; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL; TRANSMISSION ELECTRON MICROSCOPY;

ALKALINE PHOSPHATASE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLYCOSYLATION; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; LIVER; MALE; MICROSCOPY, ELECTRON; RATS; TRANSAMINASES; VANADIUM COMPOUNDS;

ANIMALIA;

EID: 20444468073     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:104:3:233     Document Type: Article

References (51)

1. W. B. Kannel and D. L. Mc Gree, Diabetes and cardiovascular disease. The Framingham Study, JAMA 241, 2035-2038 (1979).
2. H. King, R. E. Aubert, and W. H. Herman, Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care 21, 1414-1431 (1998).
3. J. Meyerovitch, Z. Farfel, J. Sack, and Y. Shechter, Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats, characterization and mode of action. J. Biol. Chem. 262, 6658-6662 (1987).
4. E. Tsiani, N. Abdullah, and I. G. Fantus, Insulin-mimetic agents vanadate and per-vanadate stimulate glucose but inhibit amino acid uptake, Am. J. Physiol. Cell Physiol. 272, 156-162 (1997).
5. K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. Pereira Redondo, Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes, J. Clin. Endocrinol. Metab. 86, 1410-1417 (2001).
6. C. E. Heyliger, A. G. Tahiliani, and J. H. McNeill, Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats, Science 227, 1474-1477 (1985).
7. M. Bendayan and D. Gingras, Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats, Diabetologia 32, 561-567 (1989).
8. M. H. Oster, J. M. Llobet, J. L. Domingo, J. B. German, and C. L. Keen, Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects, Toxicology 83, 115-130 (1993).
9. S. Verma, M. C. Cam, and J. H. McNeill, Nutritional factors that can favorably influence the glucose/insulin system: vanadium, J. Am. Coll. Nutr. 17, 11-18 (1998).
10. A. K. Srivastava, Anti-diabetic and toxic effects of vanadium compounds, Mol. Cell Biochem. 206, 177-182 (2000).
11. M. Barbagallo, L. J. Dominguez, and L. M. Resnick, Insulin-mimetic action of vanadate: role of intracellular magnesium, Hypertension 38, 701-704 (2001).
12. A. Abiko, M. Eto, I. Makino, N. Araki, and S. Horiuchi, Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay Metabolism 49, 567-573 (2000).
13. S. Pugazhenti, J. Angel and R. Khandelwal, Long-term effects of vanadate treatment on glycogen metabolism and lipogenic enzymes of liver in genetically diabetic (db/db) mice, Metabolism 40, 941-946 (1991).
14. K. H. Thompson, Vanadium and diabetes, Biofactors 10, 43-51 (1999).
15. S. M. Brichard, B. Desbuquois, and J. Girard, Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2, Mol. Cell Endocrinol. 91, 91-97 (1993).
16. A. Jound, E. Lambert, W. Stauffacher, and A. E. Renold, Diabetogenic action of streptozotocin. Relationship of dose to metabolic response, J. Clin. Invest. 48, 2129-2139 (1969).
17. A. Relander and C. E. Raiha, Differences between the enzymatic and toluidine methods of blood glucose determination, Scand. J. Clin. Lab. Invest. 15, 221-224 (1963).
18. S. Reitman and S. A. Frankel, Colorometric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases, Am. J. Clin. Pathol. 8, 56-63 (1957).
19. K. Walter and C. Schütt, Acid and alkaline phosphatase in serum (Two point method), Methods of Enzymatic Analysis, Vol. 2, H. U. Bergmeyer, ed., Verlag Chemie GmbH, Boca Raton, FL, pp. 856-860 (1974).
20. A. Ledwozwy J. Michalak, A. Stepien, and A. Kadziolka, The relationship plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta 155, 275-284 (1986)
21. E. Beutler, Glutathione in Red Cell Metabolism. A Manual of Biochemical Methods, 2nd ed., Grune and Stratton, New York, pp. 112-114 (1975).
22. K. M. Parker, J. D. England, J. D. Casto, R. Hessel, and P. E. Goldstein, Improved colorimetric assay for glycosylated hemoglobin, Clin. Chem. 27, 669-672 (1981).
23. O. H. Lowry N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265-275 (1951).
24. J. L. Hintze, Number cruncher statistical system. Copyright North Kaysville, Utah, 84037 (801), 546-0445 (1986).
25. T. Storr, D. Mitchell, P. Buglyo, et al., Vanadyl-thiazolidinedione combination agents for diabetes therapy, Bioconjug. Chem. 14, 212-221 (2003).
26. N. Arun and N. Nalini, Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats, Plant Foods Hum. Nutr. 57, 41-52 (2002).
27. T. Jackson, A. I. Salhanick, J. D. Sparks, C. E. Sparks, M. Bolognino, and J. M. Amatrude, Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes, Diabetes 37, 1234-1240 (1954).
28. S. Tamura, T. A. Brown, R. E. Dubler, and J. Larner, Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor, Biochem. Biophys. Res. Commun. 113, 80-86 (1983).
29. S. Dai, K. H. Thompson, and J. H. McNeill, One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulfate, Pharmacol. Toxicol. 74, 101-109 (1994).
30. N. Sekar, A. Kanthasamy S. William, N. Balasubramaniyan, and S. Govindasamy, Antioxidant effect of vanadate on experimental diabetic rats, Acta Diabetol. Lat. 27, 285-93 (1990).
31. E. Tsiani and I. G. Fantus, Vanadium compounds biological actions and potential as pharmocological agents, Trends Endocrinol. Metab. 8, 51-58 (1997).
32. G. Cros, J. J. Mongold, J. J. Serrano, S Ramanadham, and J. H. McNeill, Effects of vanadyl derivatives on animal models of diabetes, Mol. Cell Biochem. 109, 163-166 (1992).
33. R. M. Brand and F. G. Hamel, Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats, Int. J. Pharm. 183, 117-123 (1999).
34. S. N. Singh, P. Vats, S. Suri, et al., Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats, J. Ethnopharmacol. 76, 269-277 (2001).
35. C. M. Navarro, P. M. Montilla, A. Martin, J. Jimenez, and P. M. Utrilla, Free radical scavenger and antihepatotoxic activity of Rosmarinus, Planta Med. 59, 312-314 (1993).
36. A. W. Girotti, Lipid hydroperoxide generation, turnover, and effector action in biological systems, J. Lipid Res. 39, 1529-1542 (1998).
37. R. Kakkar, S. V. Mantha, J. Radhi, K. Prasad, and J. Kalra, Antioxidant defense system in diabetic kidney: a time course study, Life Sci. 60, 667-679 (1997).
38. S. Horie, H. Ishii, and T. Suga, Changes in peroxisomal fatty acid oxidation in the diabetic rat liver, J. Biochem. (Tokyo) 90, 1691-1696 (1981).
39. M. M. Kesavulu, B. K. Rao, R. Giri, J. Vijaya, G. Subramanyam, and C. Apparao, Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease, Diabetes Res. Clin. Prac. 53, 33-39 (2001).
40. C. C. Shih, Y. W. Wu, and W. C. Lin, Antihyperglycaemic and antioxidant properties of Anoectochilus formosanus in diabetic rats, Clin. Exp. Pharmacol. Physiol. 29, 684-688 (2002).
41. S. Venkateswaran and L. Pari, Effect of Coccinia indica leaves on antioxidant status in streptozotocin-induced diabetic rats, J. Ethnopharmacol. 84, 163-168 (2003).
42. J. W. Baynes, Role of oxidative stress in development of complications in diabetes, Diabetes 40, 405-412 (1991).
43. S. P. Wolff and R. T. Dean, Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes, Biochem. J. 245, 243-250 (1987).
44. J. V. Hunt, C. C. Smith, and S. P. Wolff, Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose, Diabetes 39, 1420-1424 (1990).
45. R. A. Anderson, A. M. Roussel, N. Zouari, S. Mahjoub, J. M. Matheau, and A. Kerkeni, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J. Am. Coll. Nutr. 20, 212-218 (2001).
46. K. Tashima, A. Fujita, and K. Takeuchi, Aggravation of ischemia/reperfusion-induced gastric lesions in streptozotocin-diabetic rats, Life Sci. 67, 1707-1718 (2000).
47. M. Brownlee, H. Vlassara, and A. Cerami, Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann. Intern. Med. 101, 527-537 (1984).
48. D. K. Yue, S. Mc Lennan, and J. R. Turtle, Non-enzymatic glycosylation of tissue protein in diabetes in the rat, Diabetologia 24, 377-381 (1983).
49. R. Yanardag, S. Bolkent, O. Karabulut-Bulan, and S. Tunalí, Effects of vanadyl sulfate on kidney in experimental diabetes, Biol. Trace Elem. Res. 95, 73-85 (2003).
50. T. Wronska-Nofer, J. Wisniewska-Knypl, E. Dziubaltowska, and K. Wyszynka, Prooxidative and genotoxic effect of transition metals (cadmium, nickel, chromium, and vanadium) in mice. Trace Elem. Electrolytes 16, 87-92 (1999).
51. S. J. Stohs and D. Bagchi, Oxidative mechanisms in the toxicity of metal ions, Free Radic. Res. Commun. 9, 101-102 (1995).